Skip to content
NBDC Human Database

No datasets in the cart.

Due to system maintenance, the application system, application review by the Data Access Committee will be unavailable during the following period.
Schedule: October 5th (Mon), 2026, 9:00 - October 7th (Wed), 2026, 15:00 (JST)
We apologize for any inconvenience this may cause and appreciate your understanding.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Dataset ID

JGAD001024

Type of data
NGS (Exome, RNA-seq)
Access criteria
Controlled-access (Type I)
Total data volume
186 GB
File formats
  • FASTQ
Research
hum0201
Date published
2026-04-22
Date modified
2026-04-22

Analysis method

WES

Materials and participants
Duodenal adenoma (ICD10: D13.2): 3 cases (6 samples)
organoids derived from duodenal tumor tissues: 3 cases (3 samples)
organoids derived from normal duodenal tissues: 3 cases (3 samples)
  • Health status
    Mixed
  • Subject count
    6 (Sample)
Disease
Duodenal adenoma (D132)
Sample description
DNAs extracted from organoids established from tumor and normal tissues
  • Tissue
    Duodenum, Organoid
  • Tumor / normal
    Mixed
Sample provider
N/A
Experimental method
WES
Target
N/A
Reagent kit
SureSelect Human All Exon V6
Fragmentation
Ultrasonic fragmentation
Platform
Illumina NovaSeq 6000
Read type
Paired-end
Read length
150 bp

RNA-seq

Materials and participants
Colon cancer (ICD10: C18): 3 cases (22 samples)
organoids derived from normal ileum tissues: 2 cases (6 samples)
genetically engineered normal ileum organoids: 2 cases (12 samples)
organoids derived from normal colon tissues: 1 case (2 samples)
genetically engineered normal colon organoids: 1 case (2 samples)
Duodenal adenoma (ICD10: D13.2): 3 cases (12 samples)
organoids derived from duodenal tumor tissues: 3 cases (6 samples)
organoids derived from normal duodenal tissues: 3 cases (6 samples)
Stomach cancer (ICD10: C16): 1 case (4 samples)
organoids derived from normal duodenal tissues: 1 case (2 samples)
genetically engineered normal duodenal organoids: 1 case (2 samples)
1 healthy individual
organoids derived from normal duodenal tissues: 1 case (2 samples)
genetically engineered normal duodenal organoids: 1 case (2 samples)
  • Health status
    Mixed
  • Subject count
    72 (Sample)
Disease
Colon cancer (C18)
Duodenal adenoma (D132)
Stomach cancer (C16)
Sample description
RNAs extracted from organoids established from tumor and normal tissues or genetically engineered organoids
  • Tissue
    Colon, Duodenum, Ileum, Organoid
  • Tumor / normal
    Mixed
Cell line
Genetically engineered normal colon organoid
Genetically engineered normal duodenal organoid
Genetically engineered normal ileum organoid
Sample provider
N/A
Experimental method
RNA-seq
Target
N/A
Reagent kit
TruSeq RNA Library Prep Kit
Fragmentation
Heat treatment
Platform
Illumina NovaSeq 6000
Read type
Paired-end
Read length
150 bp